AryoGen Pharmed Co.
Quick facts
Marketed products
- Novoseven · Other
Phase 3 pipeline
- Bevacizumab + FOLFIRI-3 · Oncology
Bevacizumab blocks VEGF to inhibit tumor angiogenesis, while FOLFIRI-3 (fluorouracil, leucovorin, and irinotecan) provides chemotherapy-induced DNA damage and cell death. - Eptacog alfa, biosimilar · Hematology
Eptacog alfa is a recombinant activated Factor VII that bypasses upstream coagulation defects to directly activate Factor X and initiate thrombin generation for hemostasis.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: